The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Access to immune checkpoint inhibitors (ICI) in patients randomized to the control arm of ICI phase 3 trials in urothelial and renal cell cancers.
 
Abby Grier
No Relationships to Disclose
 
Albert Jang
Honoraria - RealTimeCase
 
Jeffrey Zhong
No Relationships to Disclose
 
Hamsa Kumar
No Relationships to Disclose
 
Tanya Jindal
No Relationships to Disclose
 
Adam Calaway
No Relationships to Disclose
 
Angela Jia
Consulting or Advisory Role - Blue Earth Diagnostics; Myovant Sciences
Travel, Accommodations, Expenses - Myovant Sciences
 
Pingfu Fu
No Relationships to Disclose
 
Laura Bukavina
Leadership - European Urology; Urology times
Consulting or Advisory Role - Charite; ImmunityBio; Pfizer
Research Funding - American Urological Association; BCAN; Kidney Cancer Association
 
Rashed Ghandour
No Relationships to Disclose
 
Jonathan Shoag
No Relationships to Disclose
 
Amanda Nizam
Honoraria - Aptitude Health; ASCO; Cleveland Clinic; Doximity; IntegrityCE; Mashup Media (GU Oncology Now); MECC Global Meetings; Targeted Oncology
Consulting or Advisory Role - Astellas Pharma; AVEO; EMD Serono/Merck; Mashup Media (GU Oncology Now); Medscape; Pfizer/Seagen
Travel, Accommodations, Expenses - ASCO; Mashup Media; MECC Global Meetings
 
Christopher Wee
Consulting or Advisory Role - Alphasights; Alphasights; Aptitude Health; Bayer HealthCare Pharmacuticals; Capvision; ClarityCo; Curio Science; DocDelta; Janssen; MJH Life Sciences; The Dedham Group
Research Funding - Merck
 
Moshe Ornstein
Consulting or Advisory Role - AVEO; Bristol Myers Squibb Foundation; Eisai; Exelixis; Merck; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Aravive (Inst); Arcus Biosciences (Inst); Astellas Medivation (Inst); AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); HiberCell (Inst); Merck (Inst); Pfizer (Inst); Surface Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Exelixis; Merck; Pfizer
 
Jason Brown
Honoraria - AstraZeneca
Consulting or Advisory Role - EMD Serono; Johnson & Johnson/Janssen; Pfizer
Speakers' Bureau - EMD Serono
Research Funding - Bicycle Therapeutics (Inst); Merck (Inst); Novita Pharmaceuticals (Inst); Pfizer (Inst); Seagen (Inst)
 
Shilpa Gupta
Stock and Other Ownership Interests - BioNTech SE; Moderna Therapeutics; Nektar
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb/Medarex; EMD Serono; Foundation Medicine; Genzyme; Gilead Sciences; Merck; Natera; Pfizer; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Seagen
Research Funding - Bristol Myers Squibb Foundation (Inst); EMD Serono (Inst); Exelixis (Inst); Gilead Sciences (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); QED Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate author royalty
Travel, Accommodations, Expenses - Pfizer
 
Jorge Garcia
Honoraria - Aptitude Health; Astellas Pharma; MJH Associates; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Macrogenics; Pfizer; Targeted Oncology
Research Funding - Exelixis (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Premier, Inc. (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Novartis; Pfizer
Other Relationship - FDA
 
Pedro Barata
Honoraria - UroToday
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Ipson; Merck; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Bayer (Inst); Caris Life Sciences (Inst); Merck; Pfizer/Astellas (Inst)
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Exelixis; Merck (Inst); Pfizer (Inst)